Pristech Products

Pristech Products, Inc. was a medical device company based in San Antonio, Texas, that specialized in the development of innovative vascular access solutions for patients with end-stage renal disease. The company's primary product was the Pristine Long-Term Hemodialysis Catheter, which featured a unique symmetric tip design intended to optimize blood flow and minimize recirculation during dialysis treatments. By addressing common clinical challenges such as catheter-related thrombosis and infection, Pristech's technology aimed to improve the efficiency of hemodialysis and patient outcomes. In July 2011, the company was acquired by C. R. Bard, Inc., and its product line was integrated into the Bard Access Systems division. Following the acquisition of Bard by Becton Dickinson (BD) in 2017, these technologies remain part of the BD vascular access portfolio.